Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021

SELL
$25.79 - $42.11 $989,381 - $1.62 Million
-38,363 Closed
0 $0
Q1 2021

May 14, 2021

SELL
$38.75 - $86.92 $175,692 - $394,095
-4,534 Reduced 10.57%
38,363 $1.58 Million
Q4 2020

Feb 02, 2021

BUY
$34.61 - $123.66 $216,277 - $772,751
6,249 Added 17.05%
42,897 $1.86 Million
Q3 2020

Nov 05, 2020

BUY
$37.49 - $63.19 $270,527 - $455,979
7,216 Added 24.52%
36,648 $1.57 Million
Q2 2020

Aug 12, 2020

BUY
$12.66 - $58.27 $372,609 - $1.72 Million
29,432 New
29,432 $1.38 Million

Others Institutions Holding ARCT

About Arcturus Therapeutics Holdings Inc.


  • Ticker ARCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,576,400
  • Market Cap $457M
  • Description
  • Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...
More about ARCT
Track This Portfolio

Track California Public Employees Retirement System Portfolio

Follow California Public Employees Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.